Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gemcitabine (gemzar) (1 trial)
gimeracil (1 trial)
oteracil (1 trial)
s-1 (1 trial)
tegafur (1 trial)
toripalimab (LOQTORZ) (1 trial)
Biliary Tract Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (6 total)